Japan’s MHLW approves Sarepta’s gene therapy for DMD

Japan’s MHLW has approved Sarepta Therapeutics’ gene therapy Elevidys for treating Duchenne muscular dystrophy (DMD)

May 14, 2025 - 06:00

Japan’s MHLW approves Sarepta’s gene therapy for DMD

Japan’s MHLW has approved Sarepta Therapeutics’ gene therapy Elevidys for treating Duchenne muscular dystrophy (DMD)

Read the original article

Tags:

Previous Article

GSK and iTeos drop anti-TIGIT drug following trial failure

Orphan drug market access in Europe: HTA challenges and the growing potential of...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs

Vaxcyte and Lonza sign new commercial manufacturing agr...

Oct 17, 2023

RFK Jr. thrusts domestic manufacturing agenda on Day 2 of confirmation hearings

RFK Jr. thrusts domestic manufacturing agenda on Day 2 ...

Feb 1, 2025

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Eli Lilly sues Mochi Health and others for ‘deceptive’ ...

Apr 24, 2025